Spotlight
Cancer Type
About CURE
Sign Up for eNews
Historic and Current Treatment Options for mUM
An expert provides an overview of the historical and currently available treatment options in metastatic uveal melanoma (mUM), including the bispecific T-cell receptor immunotherapy tebentafusp (“teh-BEN-tah-fuhsp”).
EP: 1.How Uveal Melanoma Differs from Cutaneous Melanoma
EP: 2.Common Symptoms of Uveal Melanoma and the Typical Diagnostic Journey of the Patient
Now Viewing
EP: 3.Historic and Current Treatment Options for mUM
EP: 4.Implications of Clinical Trial Data on Bispecific T-Cell Receptor Immunotherapy for mUM
EP: 5.Patient Eligibility and Logistical and Safety Considerations for Tebentafusp Treatment in mUM
EP: 6.An Expert’s Experience in Prescribing Tebentafusp and Other Therapies for mUM and a Commentary on Patient Education and Resources
EP: 7.Treatment Options for Patients with mUM Who Are Ineligible for Bispecific T-Cell Receptor Immunotherapy
EP: 8.Advice for Patients Living with Metastatic Uveal Melanoma
Related Videos
Related Content
